These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 28042046)

  • 1. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
    Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L
    Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase.
    Guo J; Gu X; Zheng M; Zhang Y; Chen L; Li H
    Bioorg Chem; 2019 Jun; 87():16-22. PubMed ID: 30852233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.
    Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.
    Pacold ME; Brimacombe KR; Chan SH; Rohde JM; Lewis CA; Swier LJ; Possemato R; Chen WW; Sullivan LB; Fiske BP; Cho S; Freinkman E; Birsoy K; Abu-Remaileh M; Shaul YD; Liu CM; Zhou M; Koh MJ; Chung H; Davidson SM; Luengo A; Wang AQ; Xu X; Yasgar A; Liu L; Rai G; Westover KD; Vander Heiden MG; Shen M; Gray NS; Boxer MB; Sabatini DM
    Nat Chem Biol; 2016 Jun; 12(6):452-8. PubMed ID: 27110680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
    Mullarky E; Lucki NC; Beheshti Zavareh R; Anglin JL; Gomes AP; Nicolay BN; Wong JC; Christen S; Takahashi H; Singh PK; Blenis J; Warren JD; Fendt SM; Asara JM; DeNicola GM; Lyssiotis CA; Lairson LL; Cantley LC
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1778-83. PubMed ID: 26831078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor
    Weinstabl H; Treu M; Rinnenthal J; Zahn SK; Ettmayer P; Bader G; Dahmann G; Kessler D; Rumpel K; Mischerikow N; Savarese F; Gerstberger T; Mayer M; Zoephel A; Schnitzer R; Sommergruber W; Martinelli P; Arnhof H; Peric-Simov B; Hofbauer KS; Garavel G; Scherbantin Y; Mitzner S; Fett TN; Scholz G; Bruchhaus J; Burkard M; Kousek R; Ciftci T; Sharps B; Schrenk A; Harrer C; Haering D; Wolkerstorfer B; Zhang X; Lv X; Du A; Li D; Li Y; Quant J; Pearson M; McConnell DB
    J Med Chem; 2019 Sep; 62(17):7976-7997. PubMed ID: 31365252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling the Allosteric Targeting of PHGDH at the ACT-Binding Domain with a Photoactivatable Diazirine Probe and Mass Spectrometry Experiments.
    Spillier Q; Ravez S; Dochain S; Vertommen D; Thabault L; Feron O; Frédérick R
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33477510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism.
    Zhao JY; Feng KR; Wang F; Zhang JW; Cheng JF; Lin GQ; Gao D; Tian P
    Eur J Med Chem; 2021 May; 217():113379. PubMed ID: 33756126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer.
    Zhao X; Fu J; Du J; Xu W
    Int J Biol Sci; 2020; 16(9):1495-1506. PubMed ID: 32226297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel inhibitors of human phosphoglycerate dehydrogenase by activity-directed combinatorial chemical synthesis strategy.
    Zhou X; Tan Y; Gou K; Tao L; Luo Y; Zhou Y; Zuo Z; Sun Q; Luo Y; Zhao Y
    Bioorg Chem; 2021 Oct; 115():105159. PubMed ID: 34298241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors.
    Rohde JM; Brimacombe KR; Liu L; Pacold ME; Yasgar A; Cheff DM; Lee TD; Rai G; Baljinnyam B; Li Z; Simeonov A; Hall MD; Shen M; Sabatini DM; Boxer MB
    Bioorg Med Chem; 2018 May; 26(8):1727-1739. PubMed ID: 29555419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH.
    Zheng M; Guo J; Xu J; Yang K; Tang R; Gu X; Li H; Chen L
    Food Funct; 2019 Jun; 10(6):3386-3395. PubMed ID: 31112178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH).
    Ravez S; Corbet C; Spillier Q; Dutu A; Robin AD; Mullarky E; Cantley LC; Feron O; Frédérick R
    J Med Chem; 2017 Feb; 60(4):1591-1597. PubMed ID: 28085281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review 2015-2020.
    Spillier Q; Frédérick R
    Expert Opin Ther Pat; 2021 Jul; 31(7):597-608. PubMed ID: 33571419
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges and Opportunities in the Development of Serine Synthetic Pathway Inhibitors for Cancer Therapy.
    Ravez S; Spillier Q; Marteau R; Feron O; Frédérick R
    J Med Chem; 2017 Feb; 60(4):1227-1237. PubMed ID: 27959531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
    Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
    Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
    Huang K; Jiang L; Liang R; Li H; Ruan X; Shan C; Ye D; Zhou L
    Eur J Med Chem; 2019 Apr; 168():45-57. PubMed ID: 30798052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors.
    Tan Y; Zhou X; Gong Y; Gou K; Luo Y; Jia D; Dai L; Zhao Y; Sun Q
    Cell Mol Life Sci; 2021 Dec; 79(1):27. PubMed ID: 34971423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel allosteric effectors based on the predicted allosteric sites for Escherichia coli D-3-phosphoglycerate dehydrogenase.
    Wang Q; Qi Y; Yin N; Lai L
    PLoS One; 2014; 9(4):e94829. PubMed ID: 24733054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHGDH: a novel therapeutic target in cancer.
    Lee CM; Hwang Y; Kim M; Park YC; Kim H; Fang S
    Exp Mol Med; 2024 Jul; 56(7):1513-1522. PubMed ID: 38945960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.